Back to Top Skip to main content Skip to sub-navigation

DoD Leverages GEIS Respiratory Surveillance to Respond to COVID-19

Three men in a pig pen taking samples Staff from the U.S. Navy Medical Research Unit 6, better known as NAMRU-6, perform sampling on swine and swine workers in Peru. This testing helps monitor the transmission of potential respiratory pathogens.

Recommended Content:

Armed Forces Health Surveillance Division | Coronavirus

As the COVID-19 pandemic emerged and spread around the world, the Department of Defense funded health surveillance activities to rapidly support military forces living and working in the U.S. and abroad. Armed Forces Health Surveillance Branch’s Global Emerging Infection Surveillance (GEIS) program manages a global laboratory network and uses analytical processes to detect emergent diseases and track respiratory illnesses such as influenza.

This GEIS-supported respiratory network, comprised of partnerships with Army, Navy, and Air Force public health and medical research laboratories, includes hundreds of surveillance sites in over 30 countries.

These surveillance locations are selected based on inputs from the regional laboratories and in coordination with the Geographic Combatant Commands. GEIS also funds and maintains surveillance of DoD Service members through the DoD Global Respiratory Pathogen Surveillance Program, which tests samples from over 100 sentinel site locations and is operated by the U.S. Air Force School of Aerospace Medicine. In addition, GEIS supports recruit and ship-board surveillance activities operated by Naval Health Research Center. Respiratory pathogens, bacteria and viruses that can cause diseases, present a unique challenge for recruit and ship-board populations due to their close living conditions and activities that can enable the rapid spread of infections and significantly impact force readiness.

“GEIS-funded surveillance provides the foundation for rapid testing so that a better understanding of the incidence and spread of SARS-CoV-2 virus can be established,” said U.S. Public Health Service Cmdr. (Dr.) Mark Scheckelhoff, lead for the GEIS Respiratory Infections portfolio. “Through the long-term investments to build and maintain this network of laboratory locations, we have an extensive analytical capability. GEIS has enabled our partners to respond to the ongoing pandemic and detect the presence of SARS-CoV-2 around the world.”

Through GEIS support, laboratory partners conduct many investigations including the sampling of animal markets and farm locations in four countries. These efforts include sampling of avian and swine species, as well as the workers at a particular location. Samples are then analyzed for novel influenza or other emerging pathogens with pandemic potential. 

Each laboratory within the network is able to perform highly sensitive and specific testing on respiratory samples and together process approximately 30,000 samples per year. These samples are collected in various clinics and military medical treatment facilities from individuals presenting with influenza-like-illness (ILI) symptoms.

“Due to the COVID-19 pandemic, the number of samples analyzed for the 2019-2020 season remains to be determined, but over 45,000 analytical tests on ILI samples have already been performed,” stated Army Lt. Col. (Dr.) Kevin Taylor, GEIS focus area chief.

GEIS coordinates closely with the Centers for Disease Control and Prevention and other partners to ensure the data is shared. They also present annual influenza data from DoD populations to the Food and Drug Administration, to help determine the composition of the seasonal influenza vaccine for the United States.

“GEIS coordinates information sharing activities related to the development of countermeasures, vaccines, and other interventions to support the ongoing pandemic and place the network in a good position to address future threats,” said Navy Capt. Guillermo Pimentel.

You also may be interested in...

Global Influenza Summary: January 22, 2017

Report
1/22/2017

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

Human Physiologic Responses to Cold Exposure

Infographic
1/9/2017
Human Physiologic responses to cold exposure preserve core body temperature, but those responses may not be sufficient to prevent hypothermia if heat loss is prolonged. This infographic offers helpful information on preserving core body temperature to counter the threat from cold environments. Physiologic responses include: •	Constriction of the peripheral (superficial) vascular system – may result in non-freezing injuries or hasten the onset of actual freezing of tissues (frostbite) •	Minimizing loss of body heat •	Protecting superficial tissues Protection includes:	 •	Nutrition •	Shelter •	Physical Activity •	Protective Clothing Learn more about preserving core body temperature by reading the Medical Surveillance Monthly Report at www.Health.mil/AFHSB

Human Physiologic responses to cold exposure preserve core body temperature, but those responses may not be sufficient to prevent hypothermia if heat loss is prolonged. This infographic offers helpful information on preserving core body temperature to counter the threat from cold environments.

Recommended Content:

Winter Safety | Armed Forces Health Surveillance Division

Global Influenza Summary: January 1, 2017

Report
1/1/2017

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

Rift Valley Fever Virus Ecology

Infographic
12/5/2016
This infographic describes Rift Valley Fever (RVF) virus ecology and how RVF infects livestock and humans.   •	First the enzootic cycle begins. It is maintained via transfer from parent mosquito to offspring. This is a local, low-level transfer of disease to livestock and happens during periods of average rainfall. •	Next, high rainfall and flooding enable Aedes mosquito breeding environments to flourish. This is followed by epizootic outbreaks, which cause abortion storms in animals, with > 90% mortality in newborns and 10-20% mortality in adults. Secondary vectors, including other mosquito genera such as Culex, can pass on the virus to humans and animals.  Spillover to humans includes exposure to blood and tissue of infected livestock and occurs during slaughter or birthing activities. Humans can also be infected with RVF via bites of infected mosquitos.

This infographic describes Rift Valley Fever (RVF) virus ecology and how RVF infects livestock and humans.

Recommended Content:

Armed Forces Health Surveillance Division | Mosquito-Borne Illnesses | Bug-Borne Illnesses

Global Influenza Summary: November 20, 2016

Report
11/20/2016

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

Global Influenza Summary: November 6, 2016

Report
11/6/2016

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

Department of Defense continues commitment to Global Health Security Agenda

Article
10/12/2016
Dr. Karen Guice, acting assistant secretary of Defense for Health Affairs, addressed attendees on the second day of the 2016 Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury (TBI) Summit Sept. 14, 2016.

Department of Defense and other senior U.S. government leaders travel to the Netherlands to attend a summit on the Global Health Security Agenda

Recommended Content:

Health Readiness | Global Health Engagement | Building Partner Capacity and Interoperability | Global Health Security Agenda | Armed Forces Health Surveillance Division

Global Influenza Summary: October 2, 2016

Report
10/2/2016

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

Global Influenza Summary: September 3, 2016

Report
9/3/2016

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

Preserving the Health of U.S. Armed Forces with DMSS and DoDSR

Infographic
7/13/2016
The Defense Medical Surveillance System (DMSS) and the DoD Serum Repository (DoDSR) provide unprecedented capabilities for conducting comprehensive population-based surveillance of the U.S. Armed Forces while protecting the privacy and confidentiality of service members. The systems together provide glimpses of the capabilities and potential uses of public health surveillance systems of the future.  The research advantages of the DMSS and DoDSR The DMSS and DoDSR enable researchers to focus time and attention on solving methodological problems, interpreting results, producing summaries and reports.  DMSS includes personnel data, medical data, laboratory data, deployment data, and DoDSR data. Benefactors of the DMSS and DoDSR are epidemiologists, preventive medicine doctors, data analysts, DoD policy makers, Military Commanders and public health officers. Learn how to harness the full value of the DMSS and DoDSR at www.Health.mil/AFHSB

The Defense Medical Surveillance System (DMSS) and the DoD Serum Repository (DoDSR) provide unprecedented capabilities for conducting comprehensive population-based surveillance of the U.S. Armed Forces.

Recommended Content:

Armed Forces Health Surveillance Division | Defense Medical Surveillance System | DoD Serum Repository

HIV and AIDS in the U.S. Military

Infographic
6/27/2016
June 27th is National HIV Testing Day. HIV-1 infection is a major health importance for the U.S. military. Since the start of HIV-1 military health surveillance analysis during 1990-2013, service members diagnosed with the HIV-1 infection in recent years have remained longer in U.S. Armed Forces.  There were a total of 5,227 new diagnoses in 24-years of surveillance. The August 2015 Medical Surveillance Monthly Report (MSMR) reported that “Estimated median durations of service after initial HIV-1 diagnoses ranged from 2.29 years in Cohort 1 ( 1990-1994) to 3.65 years in Cohort 4 (2005-2009). Thus, in the 15 years between 1990-1994 and 2005-2009, the median durations of service after HIV-1 diagnoses increased by 1.4 years.” Factors contributing to longer service include: •	Availability and effectiveness of HIV treatments •	Decline in stigmas associated with diagnosis of the HIV infection •	Changes in U.S. military policy that allow the LGBT community to serve in its ranks  Note: Service members who are diagnosed with HIV-1 infections, regardless of their sexual orientations, may elect to continue their military service careers.  Get tested today – it’s the only way to know. Early HIV testing helps to prevent transmission and lowers the risk of severe health complications. Follow us on Twitter for more information: @AFHSBPAGE  Also on Twitter: National HIV Testing Day #NHTD

June 27th is National HIV Testing Day. HIV-1 infection is a major health importance for the U.S. military. Since the start of HIV-1 military health surveillance analysis during 1990-2013, service members diagnosed with the HIV-1 infection in recent years have remained longer in U.S. Armed Forces.

Recommended Content:

Armed Forces Health Surveillance Division | HIV/AIDS Prevention and Treatment

Global Influenza Summary: June 5, 2016

Report
6/5/2016

Global Influenza Summary: June 05, 2016

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | AFHSD Reports and Publications | Influenza Summary and Reports

The HPV Vaccine Saves Lives

Infographic
5/16/2016
The Defense Department recommends male and female military service members, ages 17-26 years, receive an HPV vaccine series to generate a robust immune response to the quadrivalent human papillomavirus vaccine (HPV4). This graphic highlights information the benefits of the HPV vaccine. The vaccine is most effective among fully vaccinated individuals.   Cancer Prevention Facts •	HPV is the most common sexually  transmitted infection (STI) •	There are more than 40 HPV types that can infect the genital areas •	Some HPV types give warts •	Some HPV types develop cancer  Effective Against STI Transmission •	The HPV vaccine is a safe and effective way to protect yourself from the virus •	The HPV vaccine provides nearly 100% protection from HPV types 6,11,16 and 18 •	HPV vaccine shows early signs of success in reducing HPV infections and related illnesses •	Protection is expected to be long-lasting  Safety Tips •	Getting your HPV vaccine and practicing safe sex such as wearing a condom may lower the risk of HPV •	Limiting the number of lifetime sex partners can also lower the risk of HPV •	When given the HPV vaccine, the body makes antibodies in response to the protection to clear it from the body  Get the Facts •	2,091 female service members aged 17-26 years received 1-3 HPV4 doses during 2006-2012, stratified by number of doses (1, 2, or 3).  Get the HPV Vaccine •	Only 22.5% of eligible service members initiated the series •	Of those, only 39.1% completed the full three-dose series as of June 2011.  Even though the 3 dose regiment provides nearly complete protection against HPV16 and HPV18, in the U.S., only 12% and 19% of female adolescents among commercial and Medicaid plans respectively complete the series.  Read HPV Facts from the CDC: https://www.ok.gov/health2/documents/IMM_Teens_HPV_Facts.pdf  Read the STI issue of the Medical Surveillance Monthly Report at Health.Mil/MSMR   Get the conversation started. Ask your healthcare provider about the HPV vaccine today. Follow us on Twitter @AFHSBPAGE and use hashtag #VaccinesWork.

The Defense Department recommends male and female military service members, ages 17-26 years, receive an HPV vaccine series to generate a robust immune response to the quadrivalent human papillomavirus vaccine (HPV4).

Recommended Content:

Medical and Dental Preventive Care Fitness | Immunizations | Men's Health | Human Papillomavirus | Armed Forces Health Surveillance Division | Women's Health

Study Finds Strong Immune Response to HPV Vaccine Among Female Service Members

Report
5/11/2016

A new study of female service members that examined their immune response to a vaccine to combat the sexually transmitted virus that causes cervical cancer showed development of antibodies in 80 to 99 percent of recipients against each of the four strains of the disease.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Public Health | Armed Forces Health Surveillance Division | Medical and Dental Preventive Care Fitness

MSMR Vol. 23 No. 7 - July 2016

Report
1/1/2016

A monthly publication of the Armed Forces Health Surveillance Branch. This issue of the peer-reviewed journal contains the following articles: Increasing severity of traumatic brain injury is associated with an increased risk of subsequent headache or migraine: a retrospective cohort study of U.S. active duty service members, 2006–2015; Use of complementary health approaches at military treatment facilities, active component, U.S. Armed Forces, 2010–2015; Incident diagnoses of cancers in the active component and cancer-related deaths in the active and reserve components, U.S. Armed Forces, 2005–2014.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Public Health
<< < ... 41 42 43 44 45  ... > >> 
Showing results 661 - 675 Page 45 of 46

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.